← Eichor
Study identifier: NCT03629418 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Targeted Blood-pressure Management and Acute Kidney Injury After Coronary Artery Bypass Surgery

Condition: Coronary Artery Bypass, Off-Pump · Intraoperative Hypotension · Acute Kidney Injury  ·  Sponsor: Peking University First Hospital

PhaseNA
Planned participants612
Who can joinAll sexes, 50 Years to no upper limit
Healthy volunteersNo

About this study

Acute renal injury (AKI) is a common complication after cardiac surgery and is associated with worse outcomes. It is now realized that intraoperative hypotension is an important risk factor for the development of AKI. In a recent randomized controlled trial of patients undergoing major noncardiac surgery, intraoperative individualized blood-pressure management reduced the incidence of postoperative organ dysfunction. The investigators hypothesize that, for patients undergoing off-pump CABG, targeted blood-pressure management during surgery may also reduce the incidence of postoperative AKI.

This description comes directly from the study's public registry record.

Talk to the study team

Dong-Xin Wang, MD, PhD  ·  8610-83572784  ·  wangdongxin@hotmail.com

Li Huang, MD, PhD  ·  8610-83572460  ·  huanglibd@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Beijing University First HospitalBeijing, Beijing Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03629418